Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-01-27 Sale |
2025-01-29 4:35 pm |
BIO-TECHNE Corp | TECH | Kelderman Kim Chief Executive Officer |
13,392 | $77.29 | $1,035,013 | 765,751 (Direct) |
View |
2021-11-19 Sale |
2021-11-23 8:02 pm |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
500 | $505.38 | $252,689 | 113,088 (Direct) |
View |
2021-09-22 Sale |
2021-09-24 4:30 pm |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
822 | $529.04 | $434,871 | 113,588 (Direct) |
View |
2021-06-09 Sale |
2021-06-11 4:59 pm |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
811 | $433 | $351,163 | 102,684 (Direct) |
View |
2021-05-25 Sale |
2021-05-27 4:26 pm |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
845 | $424 | $358,280 | 103,495 (Direct) |
View |
2021-02-05 Sale |
2021-02-09 6:31 pm |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
823 | $388.45 | $319,694 | 105,196 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-27 Exercise |
2025-01-29 4:35 pm |
N/A 2025-05-01 |
BIO-TECHNE Corp | TECH | Kelderman Kim Chief Executive Officer |
13,392 | $0 | 765,751 (Direct) |
View |
2025-01-27 Exercise |
2025-01-29 4:35 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Chief Executive Officer |
13,392 | $37.7 | 765,751 (Direct) |
View |
2024-11-01 Tax Withholding |
2024-11-05 4:47 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Chief Executive Officer |
2,430 | $75.31 | 779,143 (Direct) |
View |
2024-08-29 Exercise |
2024-09-03 4:05 pm |
N/A 2027-08-05 |
BIO-TECHNE Corp | TECH | Kelderman Kim Chief Executive Officer |
1,492 | $0 | 781,573 (Direct) |
View |
2024-08-29 Exercise |
2024-09-03 4:05 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Chief Executive Officer |
1,492 | $66.97 | 781,573 (Direct) |
View |
2024-08-15 Option Award |
2024-08-19 5:29 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Chief Executive Officer |
145,952 | $0 | 781,573 (Direct) |
View |
2024-07-31 Exercise |
2024-08-02 4:17 pm |
N/A 2025-05-01 |
BIO-TECHNE Corp | TECH | Kelderman Kim Chief Executive Officer |
14,000 | $0 | 635,621 (Direct) |
View |
2024-07-31 Exercise |
2024-08-02 4:17 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Chief Executive Officer |
14,000 | $37.7 | 635,621 (Direct) |
View |
2024-07-31 Tax Withholding |
2024-08-02 4:17 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Chief Executive Officer |
9,479 | $81.97 | 635,621 (Direct) |
View |
2024-02-01 Option Award |
2024-02-05 6:33 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Chief Operating Officer |
87,258 | $0 | 669,536 (Direct) |
View |
2023-08-15 Option Award(A) |
2023-12-14 6:13 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
32,754 | $0 | 32,754 (Direct) |
View |
2023-11-01 Option Award |
2023-11-03 6:34 pm |
N/A 2030-11-01 |
BIO-TECHNE Corp | TECH | Kelderman Kim Chief Operating Officer |
52,448 | $0 | 579,758 (Direct) |
View |
2023-08-24 Exercise |
2023-08-28 4:19 pm |
N/A 2026-08-07 |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
2,100 | $0 | 527,340 (Direct) |
View |
2023-08-24 Exercise |
2023-08-28 4:19 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
2,100 | $47.6 | 527,340 (Direct) |
View |
2023-08-15 Option Award |
2023-08-17 4:20 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
59,625 | $0 | 535,370 (Direct) |
View |
2023-08-05 Exercise |
2023-08-08 5:28 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
8,060 | $0 | 467,685 (Direct) |
View |
2023-08-05 Tax Withholding |
2023-08-08 5:28 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
4,139 | $82.17 | 467,685 (Direct) |
View |
2022-08-23 Exercise |
2022-08-25 5:38 pm |
N/A 2025-05-01 |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
663 | $0 | 126,281 (Direct) |
View |
2022-08-23 Exercise |
2022-08-25 5:38 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
663 | $150.78 | 126,281 (Direct) |
View |
2022-08-15 Option Award |
2022-08-17 5:25 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim PRES. DIAGNOSTICS & GENOM |
14,407 | $0 | 126,281 (Direct) |
View |
2022-08-07 Exercise |
2022-08-09 7:00 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
2,363 | $0 | 111,874 (Direct) |
View |
2022-08-07 Tax Withholding |
2022-08-09 7:00 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
1,214 | $382.97 | 111,874 (Direct) |
View |
2022-02-08 Exercise |
2022-02-10 4:31 pm |
N/A 2025-05-01 |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
1,989 | $0 | 113,088 (Direct) |
View |
2022-02-08 Exercise |
2022-02-10 4:31 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
1,989 | $150.78 | 113,088 (Direct) |
View |
2021-11-19 Exercise |
2021-11-23 8:02 pm |
N/A 2025-05-01 |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
500 | $0 | 113,088 (Direct) |
View |
2021-11-19 Exercise |
2021-11-23 8:02 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
500 | $150.78 | 113,088 (Direct) |
View |
2021-08-08 Exercise |
2021-08-10 6:21 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
1,691 | $0 | 114,410 (Direct) |
View |
2021-08-08 Tax Withholding |
2021-08-10 6:21 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
869 | $481.82 | 114,410 (Direct) |
View |
2021-08-06 Option Award |
2021-08-10 6:21 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
12,595 | $0 | 114,410 (Direct) |
View |
2021-05-01 Exercise |
2021-05-04 4:54 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
1,667 | $0 | 104,340 (Direct) |
View |
2021-05-01 Tax Withholding |
2021-05-04 4:54 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
856 | $427.49 | 104,340 (Direct) |
View |
2020-08-05 Option Award |
2020-08-07 6:58 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
39,644 | $0 | 106,019 (Direct) |
View |
2020-05-01 Exercise |
2020-05-05 4:28 pm |
N/A 2025-05-01 |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
1,666 | $0 | 66,375 (Direct) |
View |
2020-05-01 Tax Withholding |
2020-05-05 4:28 pm |
N/A N/A |
BIO-TECHNE Corp | TECH | Kelderman Kim Pres. Diagnostics & Genom |
821 | $227.54 | 66,375 (Direct) |
View |